Regenerative Medical Technology Group Inc. Proceeds from Long-Term Debt Issued
Regenerative Medical Technology Group Inc. (RMTG) reported Proceeds from Long-Term Debt Issued of $291.38 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2026-08-19
- Regenerative Medical Technology Group Inc. proceeds from issuance of long-term debt for the quarter ending 2026-06-30 was -$26.62K.
- Regenerative Medical Technology Group Inc. proceeds from issuance of long-term debt for the quarter ending 2026-03-31 was $318.00K.
- Regenerative Medical Technology Group Inc. proceeds from issuance of long-term debt for the quarter ending 2025-12-31 was $0.00.
- Regenerative Medical Technology Group Inc. proceeds from issuance of long-term debt for the quarter ending 2025-09-30 was $0.00.
- Regenerative Medical Technology Group Inc. proceeds from issuance of long-term debt for fiscal 2025 was $1.10M.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$26.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19 | $291.38K 10-Q · filed 2026-08-19 | $291.38K derived: sum of 3 quarters · filed 2026-08-19 | $291.38K derived: sum of 4 quarters · filed 2026-08-19 |
| 2026-03-31 | $318.00K 10-Q · filed 2026-06-09 | $318.00K derived: sum of 2 quarters · filed 2026-06-09 | $318.00K derived: sum of 3 quarters · filed 2026-06-09 | |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-14 | $0.00 derived: sum of 2 quarters · filed 2026-05-14 | $1.10M 10-K · filed 2026-05-14 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $1.10M 10-Q · filed 2025-11-19 | ||
| 2025-06-30 | $1.10M 10-Q · filed 2026-08-19 |